This was also confirmed by qRT‐PCR with significant upregulation of fibronectin (FN1), fascin (FSCN1), and the receptor tyrosine kinase AXL, which has been associated with EMT, tumor cell invasion, and therapy resistance in different tumor entities [49] (Fig. 5C). This evidence concerns the gene NTRK1 and neoplasm.